CRISPR/Cas9-mediated miR-21 editing in high-grade urothelial carcinoma cells and its biological effects.

Mol Biol Rep · 2026 · PMC13282212 · PMID 42319574

Europe PMC DOI

hedged sentence

0.0563

closest p · 1.1× alpha

0.0563

boldest claim

The sentences

showed a trendp = 0.0563so close (0.05 < p ≤ 0.1)

did not reach statistical significanceno p-value reported

Results CRISPR/Cas9 treatment targeting miR-21 showed a trend toward reduced miR-21 expression (p = 0.0563), although this did not reach statistical significance.

also in 33,481 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.